Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

2.

Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.

Azios NG, Krishnamoorthy L, Harris M, Cubano LA, Cammer M, Dharmawardhane SF.

Neoplasia. 2007 Feb;9(2):147-58.

3.

Flavonoid effects relevant to cancer.

Brownson DM, Azios NG, Fuqua BK, Dharmawardhane SF, Mabry TJ.

J Nutr. 2002 Nov;132(11 Suppl):3482S-3489S.

PMID:
12421874
4.
5.

Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells.

Mezi S, Todi L, Orsi E, Angeloni A, Mancini P.

Int J Oncol. 2012 Dec;41(6):2128-38. doi: 10.3892/ijo.2012.1642. Epub 2012 Sep 26.

PMID:
23023326
6.

Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.

Tsonis AI, Afratis N, Gialeli C, Ellina MI, Piperigkou Z, Skandalis SS, Theocharis AD, Tzanakakis GN, Karamanos NK.

FEBS J. 2013 May;280(10):2248-59. doi: 10.1111/febs.12162. Epub 2013 Feb 27.

7.

Epidermal growth factor increased the expression of alpha2beta1-integrin and modulated integrin-mediated signaling in human cervical adenocarcinoma cells.

Yamanaka I, Koizumi M, Baba T, Yamashita S, Suzuki T, Kudo R.

Exp Cell Res. 2003 Jun 10;286(2):165-74.

PMID:
12749846
8.
10.

Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.

Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, Shupnik MA.

Mol Endocrinol. 2005 Nov;19(11):2660-70. Epub 2005 Jun 23.

PMID:
15976008
11.

Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP.

Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, Simoncini T.

Mol Endocrinol. 2010 Nov;24(11):2114-25. doi: 10.1210/me.2010-0252. Epub 2010 Sep 29.

12.

ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.

Schlienger S, Ramirez RA, Claing A.

Cell Signal. 2015 Mar;27(3):403-15. doi: 10.1016/j.cellsig.2014.11.032. Epub 2014 Dec 19.

PMID:
25530216
13.

Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells.

Golubovskaya V, Beviglia L, Xu LH, Earp HS 3rd, Craven R, Cance W.

J Biol Chem. 2002 Oct 11;277(41):38978-87. Epub 2002 Aug 7.

14.
15.
16.

Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.

Crean JK, Furlong F, Finlay D, Mitchell D, Murphy M, Conway B, Brady HR, Godson C, Martin F.

FASEB J. 2004 Oct;18(13):1541-3. Epub 2004 Aug 19.

PMID:
15319369
17.

The tyrosine phosphatase SHP2 regulates focal adhesion kinase to promote EGF-induced lamellipodia persistence and cell migration.

Hartman ZR, Schaller MD, Agazie YM.

Mol Cancer Res. 2013 Jun;11(6):651-64. doi: 10.1158/1541-7786.MCR-12-0578. Epub 2013 Mar 19.

18.

Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells.

Bartholomew PJ, Vinci JM, DePasquale JA.

J Steroid Biochem Mol Biol. 1998 Nov;67(3):241-9.

PMID:
9879983
19.

Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells.

Shortrede JE, Uzair ID, Neira FJ, Flamini MI, Sanchez AM.

Mol Cell Endocrinol. 2016 Jul 15;430:56-67. doi: 10.1016/j.mce.2016.04.007. Epub 2016 Apr 16.

PMID:
27095481
20.

Supplemental Content

Support Center